Elizabeth H.z. Thompson - 30 Sep 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 19:59:03 UTC
Previous filing
13 Aug 2024
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +1,452 +50% $0.000000 4,356 30 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects partial payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.